Parasites

Autoantibody tests
Hemagglutination test Latex flocculation test Test for toxoplasmosis W E RECENTLY REPORTED a controlled study of serum viral antibody titers in patients with primary myocardial disease (PMD); there was no association between infection with Coxsackie viruses B 1-6, echoviruses 6 and 9, and influenza A and B, mumps, herpes simplex, or psittacosis viruses, as determined by viral antibody titers, and the occurrence of chronic primary myocardial disease.' However, other sero-immunological studies in the recent literature,2-7 suggested that an autoimmune response may be an etiological factor in patients with primary myocardial disease; Chagas' disease,8-10 toxoplasmosis,'1 and rheumatoid disease12-14 have also been reported as causative of cardiomyopathy. We, therefore, extended our controlled study to include evaluation of sero- 
Methods
Thirty-four patients with chronic primary myocardial disease and 71 control subjects were studied; these are the same patient groups described in the previous report.
Primary myocardial disease patients were selected from the Cardiac Clinics at Grady Memorial Hospital. All 34 patients diagnosed as having PMD met the following criteria: (1) No clinical evidence of atherosclerotic, rheumatic, congenital, metabolic, hypertensive, infectious, toxic (excluding alcohol intake), hypersensitive, infiltrative, neuromuscular or familial myocardial disease (New York Heart Association Criteria);
(2) no evidence of collagen disease, pregnancy, or the immediate postpartum state (8 to The majority of the PMD patients were Negro (29/34); the remainder were Caucasian. There were 12 males and 22 females.
For each PMD patient, two icontrol subjects of comparable age, sex, race, and socio-economic status were selected from the General Medical Clinics of Grady Memorial Hospital. Excluded from this control group were patients with rheumatic heart disease, with serum globulin abnormalities, with malignancy, and with acute or chronic infection. Serological analysis was done on a 10-ml sample of venous blood. All blood samples from both PMD patients and control subjects were taken during a 30-day period in April and May 1966 Heart fluorescent 9 15 antibody test (52 +) 34 71
Evaluation of heart autoantibodies employed the criteria of Kaplan and associates, which interpreted a reaction of 2+ or greater intensity as a positive response. Sera from all PMD patients and control subjects were tested, at one-half dilution, against two different human heart specimens obtained at postmortem examination. There was no statistical difference in the percentage of sera with > 2+ heart fluorescent antibody reaction between the PMD patients and their control subjects (table 2) . Age, sex, race, disease duration, and alcohol consumption did not appear to influence the incidence of positive heart fluorescent antibody tests.
The complement fixation test for Chagas' disease was not positive in any of the 34 PMD patients and in two of the 71 control subjects (table 2). Both positive tests were of low titer and not considered definitive evidence of prior T. cruzi infection.
Hemagglutination studies for toxoplasmosis revealed significant titers (256 to 512) in two of the 34 PMD patients and four of the 71 control subjects (table 2). The Laboratory Branch of the Communicable Disease Center considered these tests as evidence of prior toxoplasmosis, occurring in comparable incidence in the PMD and control groups.
The latex flocculation test for the rheumatoid factor was positive in one of the 34 PMD patients and two of the 71 control subjects Discussion In 1961, Kaplan and associates2 described positive heart autoantibody immunofluorescent tests in patients with rheumatic fever, rheumatic heart disease, rheumatoid arthritis, systemic lupus erythematosus, liver disease, acute myocardial infarction, and the postcardiotomy syndrome. They considered the properties of the serum factor to be "consistent with those of immune bodies." Shaper and associates6 recently reported a high incidence of positive immunofluorescent antibody activity in patients with tropical endomyocardial fibrosis but felt that this disease might represent a modified form of rheumatic heart disease. Sanders7 described nine patients with primary myocardial disease, five of whom had gamma globulin bound to the sarcolemmal and subsarcolemmal space, as compared with two of 16 control subjects with a similar change; he considered these data as inferential support of an immune process in these PMD patients.
Chagas' disease is a known cause of cardiomyopathy, characterized by inflammation and degeneration of heart muscle. Decourt and associates8 reported that 4% of patients with chronic myocardial disease had positive complement fixation tests for Chagas' disease. Rosenbaum" theorized that a toxic or immunoallergic reaction occurs in heart muscle fibers following invasion and destruction by T. cruzi; this reaction results in antigen formation. Chagas' disease is not uncommonly encountered today in South Texas, where the complement fixation test is considered a reliable screening technique. Nine of 500 individuals in this area studied serologically had significant elevations of complement fixing antibody to T. cruzi; none of these individuals had clinical evidence of heart disease at time of study.10 Toxoplasma gondii produces focal necrosis and pseudocysts in the myocardium, similar Circ,ulation, Volume XXXVII, June 1968 Serological tests Chagas' disease to the pathological alteration seen in Chagas' disease. Cardiomyopathy may be a late sequel to toxoplasmosis and investigation for prior toxoplasmosis has been suggested for all patients with obscure cardiomyopathy.11
Ten of 100 patients with rheumatoid arthritis were reported by Cruickshank'2 to have nonspecific myocarditis. Gowans'3 demonstrated myocardial granulomas in patients with rheumatoid disease who had rheumatoid nodules, arthritis, and high serum titers of the rheumatoid factor. Weintraub and Zvaifler'4 also described pathological myocardial alteration in patients with rheumatoid arthritis, usually associated with high serum titers of the rheumatoid factor, with many subcutaneous granulomas and occasionally with aortic insufficiency. The extension of our previous sero-immunological studies to include evaluation of autoimmune heart disease, for Chagas' disease, for toxoplasmosis, and for rheumatoid disease has not further elucidated the etiology of primary myocardial disease. These further negative sero-immunological results inferentially support the absence of etiological association between the viruses, parasites, and autoimmune responses studied and chronic primary myocardial disease.
